Gene Expression Analysis Market - Global Forecasts to 2020

The global gene expression analysis market is projected to grow at a CAGR of 9.3% from 2015 to 2020 to reach 5.30 billion by 2020. The global gene expression analysis market is expected to witness moderate growth in the coming years. The availability of funding, growth in the number of cancer patients, strong focus on research, and the decreasing cost of sequencing are the major factors driving the growth of the gene expression analysis markets. The increasing focus on precision medicines and adoption amongst emerging countries provides attractive/lucrative growth opportunities for the market. However, the high cost of certain instruments poses as a market restraint while the currency devaluation in developing countries poses as challenge for the market.

In 2015, the services segment is expected to grow at the fastest CAGR from 2015 to 2020 in the global gene expression analysis market, by type. The insights obtained through gene expression profiling play a vital role in the advancement of disease diagnosis, drug discovery, and precision medicine. This is expected to boost the demand for gene expression profiling services in the coming years.

In 2015, North America is expected to account for the largest share of the global gene expression analysis market, followed by Europe, Asia, and the Rest of the World (RoW). Asia-Pacific is expected to be the fastest growing regional segment from 2015 to 2020. North America’s large share is attributed to development of gene therapy in the U.S., and focus on gene expression studies to improve the quality of patient care. Increasing research activities on agriculture, government intervention to improve healthcare, and rising popularity of gene expression tests are the factors expected to augment growth in the Asia-Pacific region.

The market witnesses high competitive intensity, as there are few large players and several small players. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.
Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), and PerkinElmer (U.S.). are few of the major players in the global gene expression analysis market.


Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned four strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on the product portfolios of top players in the gene expression analysis market. The report analyzes the gene expression analysis market, by product, services, and by application
‧ Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the gene expression analysis market
‧ Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis markets across regions
‧ Competitive Assessment: In-depth assessment of market shares, and strategies of the leading players in the gene expression analysis market

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 18
1.3.2 YEARS CONSIDERED FOR THE STUDY 19
1.4 CURRENCY 19
1.5 PACKAGE SIZE 19
1.6 LIMITATIONS 19
1.7 STAKEHOLDERS 20
2 RESEARCH METHODOLOGY 21
2.1 RESEARCH METHODOLOGY STEPS 21
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 22
2.2.1 SECONDARY RESEARCH 22
2.3 KEY DATA FROM SECONDARY SOURCES 22
2.3.1 PRIMARY RESEARCH 23
2.3.2 KEY INDUSTRY INSIGHTS 24
2.4 KEY DATA FROM PRIMARY SOURCES 25
2.5 KEY INSIGHTS FROM PRIMARY SOURCES 26
2.6 MARKET SIZE ESTIMATION METHODOLOGY 26
2.7 MARKET FORECAST METHODOLOGY 28
2.8 MARKET DATA VALIDATION AND TRIANGULATION 29
2.9 ASSUMPTIONS FOR THE STUDY 29
3 EXECUTIVE SUMMARY 30
3.1 INTRODUCTION 30
4 PREMIUM INSIGHTS 35
4.1 GLOBAL GENE EXPRESSION ANALYSIS MARKET OVERVIEW 35
4.2 GEOGRAPHIC ANALYSIS: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT 36
4.3 GEOGRAPHICAL SNAPSHOT OF THE GENE EXPRESSION ANALYSIS MARKET 37
4.4 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 38
?
5 INDUSTRY INSIGHTS 39
5.1 VALUE CHAIN ANALYSIS 39
5.2 PORTER’S FIVE FORCES ANALYSIS 40
5.2.1 THREAT OF NEW ENTRANTS 40
5.2.2 THREAT OF SUBSTITUTES 40
5.2.3 BARGAINING POWER OF BUYERS 41
5.2.4 BARGAINING POWER OF SUPPLIERS 41
5.2.5 COMPETITIVE RIVALRY AMONG EXISTING FIRMS 41
5.3 INDUSTRY VIEWS/INSIGHTS/ INDUSTRY TALKS 41
6 MARKET OVERVIEW 42
6.1 INTRODUCTION 43
6.2 MARKET SEGMENTATION 43
6.3 MARKET DYNAMICS 44
6.3.1 DRIVERS 44
6.3.1.1 Decreasing cost of sequencing 44
6.3.1.2 Growth in the number of cancer patients 45
6.3.1.3 Availability of government funding 45
6.3.1.4 Use of microarray technology to aid gene expression studies 45
6.3.1.5 SBS technology to aid more detailed cancer studies 46
6.3.1.6 Availability of gene expression databases 46
6.3.2 RESTRAINTS 47
6.3.2.1 High cost of instruments 47
6.3.2.2 Shortage of trained professionals 47
6.3.3 OPPORTUNITIES 48
6.3.3.1 Emerging countries to provide growth opportunities 48
6.3.3.1.1 Collaborative efforts in China aimed at improving the quality of healthcare 48
6.3.3.1.2 Strong focus on the biotechnology sector in India 48
6.3.3.1.3 Government funding for research in Brazil 49
6.3.3.2 Growing government focus on personalized medicine 49
6.3.4 CHALLENGE 50
6.3.4.1.1 Currency Devaluation 50
7 GENE EXPRESSION ANALYSIS MARKET, BY CONSUMABLES 51
7.1 INTRODUCTION 52
7.2 REAGENTS 55
7.3 DNA CHIPS 55
?
8 GENE EXPRESSION ANALYSIS INSTRUMENTS MARKET, BY TECHNOLOGY 57
8.1 INTRODUCTION 58
8.2 POLYMERASE CHAIN REACTION (PCR) 59
8.3 NEXT-GENERATION SEQUENCING (NGS) 60
8.3.1 COST AND SPEED OF NGS 61
8.3.2 SUBSTITUTION OF MICROARRAY TECHNOLOGY BY NGS 61
8.3.3 RESEARCH LABORATORIES AND ACADEMICIANS PROMOTING NGS 62
8.3.4 GLOBAL ALLIANCES AMONG LEADING RESEARCH INSTITUTES TO ASSIST DRUG DISCOVERY AND INCREASE THE DEMAND FOR NGS 62
8.4 DNA MICROARRAY 63
8.5 OTHERS 63
8.5.1 SERIAL ANALYSIS OF GENE EXPRESSION 63
8.5.2 NORTHERN BLOTTING 64
9 GENE EXPRESSION ANALYSIS MARKET, BY SERVICE 65
9.1 INTRODUCTION 66
9.2 GENE EXPRESSION PROFILING SERVICES 68
9.2.1 SEQUENCING SERVICES 70
9.2.2 OTHER SERVICES 70
9.3 BIOINFORMATICS SOLUTIONS 71
10 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATIONS 72
10.1 INTRODUCTION 73
10.2 RESEARCH 74
10.3 DRUG DISCOVERY 75
10.4 DIAGNOSTICS 76
10.5 OTHER APPLICATIONS 77
11 GENE EXPRESSION MARKET, BY REGION 78
11.1 INTRODUCTION 79
11.2 NORTH AMERICA 80
11.2.1 U.S. 82
11.2.1.1 Development of gene therapy in the U.S. 82
11.2.1.2 Focus on gene expression studies to improve quality of patient care 83
11.2.1.3 Precision Medicine Initiative 83
11.2.1.4 Government Funding 83
11.2.2 CANADA 85
11.2.2.1 Gene expression profiling tests in Canada 85
11.2.2.2 Government Initiatives 85
11.2.2.3 Government funding for NGS 86
?
11.3 EUROPE 88
11.3.1 U.K. 90
11.3.1.1 U.K. project to sequence 100,000 genomes 90
11.3.1.2 Government funding in the U.K. 90
11.3.2 GERMANY 92
11.3.2.1 Conferences in Germany 92
11.3.3 FRANCE 94
11.3.3.1 Introduction of non-invasive prenatal testing in France 94
11.3.4 REST OF EUROPE (ROE) 96
11.3.4.1 Turkey to offer growth opportunities 96
11.3.4.2 Focus on Gene Therapy 96
11.3.4.3 Increasing funding for molecular diagnostics in Europe 96
11.3.4.4 Investments in rare disease research 97
11.4 ASIA PACIFIC 99
11.4.1 CHINA 101
11.4.1.1 Western partnerships in China aimed at improving healthcare 101
11.4.1.2 Domestic manufacturing of sequencing systems in China 102
11.4.1.3 Efforts of BGI to boost the Chinese market for gene expression 102
11.4.1.4 Gene expression signature for quality control of traditional Chinese medicines 102
11.4.2 JAPAN 104
11.4.2.1 Japanese government’s focus on cancer 104
11.4.2.2 Research efforts in Japan 104
11.4.3 KOREA, AUSTRALIA, AND NEW ZEALAND 106
11.4.3.1 Need to develop treatments for animals 106
11.4.3.2 Flourishing bioresearch centers & financial support in Australia 106
11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 108
11.4.4.1 Gene expression tests gaining popularity in India 108
11.4.4.2 The rise of the Indian gene expression analysis market 108
11.4.4.3 Regular funding from the Indian government, an impetus to the NGS market 109
11.4.4.4 Singapore’s strong focus on neurodegenerative diseases 109
11.5 REST OF THE WORLD (ROW) 111
11.5.1.1 Sequencing of 100,000 Genomes in the Saudi Arabia 112
11.5.1.2 Focus on HIV/AIDS genetic research in Africa 112
11.5.1.3 South American countries focus on genomic research to improve public health 112
11.5.1.4 Bioinformatics & biotechnology research in Latin America to boost the demand for NGS instruments & services 112
?
12 COMPETITIVE LANDSCAPE 115
12.1 OVERVIEW 115
12.2 MARKET SHARE ANALYSIS 116
12.2.1 THERMO FISHER SCIENTIFIC 116
12.2.2 ILLUMINA, INC. 116
12.2.3 BIO-RAD LABORATORIES 117
12.2.4 QIAGEN N.V. 117
12.3 COMPETITIVE SITUATION AND TRENDS 118
12.3.1 NEW PRODUCT LAUNCHES 118
12.3.2 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS 119
12.3.3 ACQUISITIONS 120
12.3.4 OTHER STRATEGIES 121
13 COMPANY PROFILES 122
13.1 INTRODUCTION 122
13.2 THERMO FISHER SCIENTIFIC, INC. 123
13.3 QIAGEN N.V. 126
13.4 ILLUMINA, INC. 130
13.5 BIO-RAD LABORATORIES, INC. 135
13.6 F. HOFFMANN-LA ROCHE LTD. (ROCHE) 139
13.7 AGILENT TECHNOLOGIES, INC. 142
13.8 AFFYMETRIX, INC. 146
13.9 GE HEALTHCARE 150
13.10 PERKINELMER, INC. 153
13.11 OXFORD GENE TECHNOLOGY 155
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX 157
14.1 DISCUSSION GUIDE 157
14.2 COMPANY DEVELOPMENTS (2013-2015) 161
14.2.1 THERMO FISHER SCIENTIFIC, INC. 161
14.2.2 QIAGEN N.V. 162
14.2.3 ILLUMINA INC. 163
14.2.4 ROCHE 166
14.2.5 BIO-RAD LABORATORIES 167
14.2.6 AGILENT TECHNOLOGIES, INC. 168
14.2.7 AFFYMETRIX 170
14.2.8 GE HEALTHCARE 171
14.2.9 PERKINELMER, INC. 171
14.2.10 OXFORD GENE TECHNOLOGY 172
?
14.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 173
14.4 AVAILABLE CUSTOMIZATIONS 173
14.5 RELATED REPORTS 174